Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,283 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07866131Recruiting
Observational study of PRX S cosmetic treatment for acne-prone skin
This study looks at how a cosmetic treatment called PRX S affects the appearance of acne-prone skin. You would receive 5 treatment sessions over about 8 weeks and use only the provided skincare products during the study.
Leawood, KansasAges 18 years+ - NCT06187675Recruiting
Nutrition and exercise program with choice for pregnancy
This study tests a program where you can choose your own nutrition and exercise plan during pregnancy. It aims to see if giving you options helps you and your baby stay healthy.
London, OntarioAges 18 years+ - NCT06232096RecruitingPhase 1/Phase 2
Study of MBS314 for relapsed or refractory multiple myeloma
This trial tests a new drug called MBS314 for people whose multiple myeloma has returned or stopped responding to other treatments. The goal is to see if MBS314 can help shrink or control the myeloma.
BeijingAges 18 years+ - NCT06314373RecruitingPhase 1/Phase 2
Study of a new drug for advanced solid tumors
This trial tests a new drug called HSK39775 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective for people who have few other options.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05399589Recruiting
Dental implant study using Nobel parallel implants in back teeth
This trial looks at how well a specific type of dental implant works in the back of the mouth (upper or lower). It may help patients by testing whether this implant-and-connector setup leads to good results without needing extra bone procedures.
Hangzhou, ZhejiangAges 18–70 - NCT06169956Recruiting
Study of nivolumab with chemo before lung cancer surgery
This study looks at how well the immunotherapy drug nivolumab (Opdivo) works when given with standard chemotherapy before surgery for people with a certain type of lung cancer that has not spread. It may help shrink the tumor before surgery.
Kempten (Allgäu), BavariaAges 18 years+ - NCT06252298RecruitingPhase 1
Testing a new drug for CD38-positive blood cancers
This trial tests a new drug, SCTC21C, for people with certain blood cancers (like myeloma or lymphoma) that have come back or not responded to other treatments. The goal is to see if the drug is safe and can help control the cancer.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07851220RecruitingPhase 3
Study of inebilizumab for primary membranous nephropathy
This study tests a new medicine called inebilizumab for people with primary membranous nephropathy, a kidney disease. The medicine may help reduce protein in the urine and protect kidney function.
Los Angeles, CaliforniaAges 18–79 - NCT07845487RecruitingPhase 2
Study of PALI-2108 for moderate to severe ulcerative colitis
This trial tests an experimental drug called PALI-2108 against a placebo (a dummy treatment) for people with moderate to severe ulcerative colitis. It aims to see if PALI-2108 can help reduce symptoms and improve quality of life.
Sun City, ArizonaAges 18–75 - NCT07845071RecruitingPhase 3
Cebranopadol for acute pain after surgery or injury
This study tests an investigational medication called cebranopadol to see if it safely and effectively relieves acute (short-term) pain after surgery or from a muscle or bone injury. It may offer a new option for people who need relief from moderate to severe pain.
Phoenix, ArizonaAges 18–75 - NCT07843472RecruitingPhase 3
Petrelintide for weight loss in people with heart disease
This study tests a new medication called petrelintide to help people with overweight or obesity and heart disease lose weight. It may offer a new way to manage weight and improve heart health.
Anniston, AlabamaAges 40 years+ - NCT07842640RecruitingPhase 1
Injectable treatment for overweight and obesity
This study tests an injectable medication called ASC35 to see if it is safe and tolerable for people who are overweight or obese. It may help with weight management, though it is an early-stage trial focused on safety first.
Baltimore, MarylandAges 18–65 - NCT07849231RecruitingPhase 1
Study of an experimental drug for CALR-mutant myeloproliferative neoplasms
This trial is testing an experimental drug called DMR-001 for people with blood cancers like ET or myelofibrosis who have a specific genetic change known as a CALR mutation. The goal is to see if the drug is safe, tolerable, and helps treat the disease.
Liverpool, New South WalesAges 18 years+ - NCT07843498RecruitingPhase 3
Testing a new weight-loss medicine in adults with overweight or obesity
This study tests a new medication called petrelintide to see how well it helps people lose weight and improve their health. It's for adults with overweight or obesity who have struggled to lose weight with diet alone.
Anniston, AlabamaAges 18 years+ - NCT07848659RecruitingPhase 1
Single-dose study for sleep-deprived healthy volunteers
This study tests a single dose of an investigational medicine in healthy people who are sleep-deprived. It helps researchers understand how the medicine works in the body when you haven't slept, which could lead to new treatments for sleepiness.
Eatontown, New JerseyAges 18–55 - NCT07843485RecruitingPhase 3
Weight loss medication for adults with type 2 diabetes
This study tests a new medicine called petrelintide to help people with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be an option if you've struggled with weight loss through diet alone.
Los Angeles, CaliforniaAges 18 years+ - NCT07844616Recruiting
Eggs, gut health, and metabolism study
This study looks at how eating whole eggs versus egg whites affects your gut bacteria, metabolism, and immune system. It aims to understand how eggs may influence health markers in people of different weight ranges.
Storrs, ConnecticutAges 18–50 - NCT07838220RecruitingPhase 1
Study of IBI3016 in Japanese adults with high blood pressure
This trial tests an experimental drug called IBI3016 for lowering high blood pressure. It is specifically for Japanese adults who have high blood pressure while currently on treatment.
OsakaAges 18–75 - NCT07840326RecruitingPhase 2
Study of SUN-627 for progressive multiple sclerosis
This study tests an experimental medicine called SUN-627 for people with progressive multiple sclerosis (MS) that is not currently flaring up. The goal is to see if it can slow down worsening disability without causing serious side effects.
Atlanta, GeorgiaAges 18–70 - NCT07835633RecruitingPhase 1
Safety study of a single injection of ACC085 in healthy adults
This trial tests a new medication called ACC085 given as a single injection to healthy adults. The goal is to find out how safe it is and how the body processes it.
Wuhan, HubeiAges 18–55 - NCT07836452RecruitingPhase 1
Study of a new drug for healthy people and those with Stargardt disease
This study tests a new drug called CITY-RBP4 in healthy volunteers and in people with Stargardt disease (STGD1), a genetic condition that causes vision loss. The goal is to see if the drug is safe and how it affects the body, which may help guide future treatments for Stargardt disease.
Melbourne, VictoriaAges 12–45 - NCT07840612RecruitingPhase 1
How probenecid affects mirdametinib in healthy volunteers
This study checks how probenecid (a medicine for gout) changes the levels of mirdametinib (an experimental cancer drug) in healthy people. It helps doctors understand dosing and safety before testing in patients.
Neu-UlmAges 18–65 - NCT07837778Recruiting
Balance and posture study for healthy adults
This study looks at how anchoring (a technique using hand contact) affects balance and posture in healthy adults. It may help improve balance training or rehabilitation programs.
Orlando, FloridaAges 18–50 - NCT07840092Recruiting
Blood and tissue markers for liver cancer treatment response
This study looks at blood and tissue samples from people with liver cancer to find markers that can predict how well treatment works and whether the cancer might come back. It may help doctors personalize treatment and follow-up care.
TianjinAges 18 years+
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,283 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.